Bariatric surgery
Bariatric surgery has been studied in 487 papers since 2014: 32 trials and 144 observational studies in people, 5 in animals, 299 reviews; 236 in the past year. The newest paper, Nov 19, 2026: “Preoperative Glucagon-Like Peptide–1 Receptor Agonist Therapy and Prior Bariatric Surgery in Obese Patients Undergoing Total Knee Arthroplasty: Two Parallel National Propensity-Matched Analyses”.
43 new papers in 30 daysSee all 482 papers on bariatric surgery
At a glance
Human studies link bariatric surgery with lower mortality, a link independent labs report again, although other studies show no clear mortality difference; dementia associations point both ways. A human trial reports improved physical function but reduced hip bone density, while another reports lean-mass loss. Some papers declare company ties, and some authors work at companies.
476 findings in 263 papers from 2014 to 2026, 44 of them since April 2026
Independent labs found the same change in people. 124 independent labs in 41 countries.
“At < 104 weeks, MBS achieved greater reductions than GLP-1 RAs in %TWL (ETD -10.3%; p = 0.001)”
14 of its findings point the other way.
- 124 independent labs in 41 countries
- 14 findings against
- Funders: National Institute of Diabetes and Digestive and Kidney Diseases and others
- 65 of 335 findings with company ties
- Human trial32
- Humans142
- Animals5
- In silico3
Studies in people
See all 24 studies of bariatric surgery in people24 studies gave bariatric surgery to people and measured what changed.
| What changed | Design | People | Source |
|---|---|---|---|
down: Decreases epicardial adipose tissue volume down: Decreases VLDL size up: Improves HDL particle size | Trial | 13 peopleIn normolipidemic and normoglycemic individuals with obesity | Nutrition, metabolism, and cardiovascular diseases : NMCD, Jul 29, 2026 |
down: Decreases body weight-31.1 ± 8.7 kg, -27 % down: Decreases resting metabolic rate-356 ± 237 kcal/day, -17 % down: Decreases liver volume-384 ± 250 cm3, -21 % | Randomized trial26 weeks | 47 people39.6 ± 10.6yMidlife adults; severe obesity | Clinical nutrition (Edinburgh, Scotland), Mar 11, 2026 |
down: Decreases fat mass-32% (95% CI: -45%, -19%) down: Decreases lean mass-15.1% (95% CI: -20.2%, -9.3%) | Treated cohort3 years (surgical groups) or 2 years (Diet group) | 55 peopleBoth18–70Patients with obesity undergoing four weight-loss interventions | Endocrine, Mar 9, 2026 |
down: Lowers the risk of obstructive sleep apnea-32.1 percentage points, 95% CI -36.9 to -27.2, p < 0.001 | Trial20 years | 4,047 peopleIn participants with baseline OSA | Obesity (Silver Spring, Md.), Feb 25, 2026 |
down: Decreases body weight30% weight loss after surgery at 1 year up: Increases IGFBP-2203 ng/mL (169-259) after surgery versus 153 (110-181) with LCD; P = .028 up: Increases adiponectin/leptin ratio | Trial1 year | 20 peopleAdultsBody mass index ≥35 kg/m2 | Journal of the Endocrine Society, Jan 29, 2026 |
What did studies of bariatric surgery find?
219Studies of bariatric surgery measured 219 outcomes; the most studied are body weight (59 studies), mortality (15) and type 2 diabetes (13).
Body weight
downin humans55downin reviews4−20%
59 studies
Body weight
downin humans55downin reviews4−20%
Bariatric surgery decreases body weight in humans (severe obesity) (-31.1 ± 8.7 kg, -27 %).
“Significant reductions were observed in body weight (-31.1 ± 8.7 kg, -27 %), RMR (-356 ± 237 kcal/day, -17 %), kidney volume (-35.1 ± 25.2 cm3, -11 %), and liver volume (-384 ± 250 cm3, -21 %) (p < 0.01 for all)”
Human trialsevere obesity26 weeksn = 47
Clinical nutrition (Edinburgh, Scotland)
Bariatric surgery decreases body weight in humans within 2-year postoperative period (-44 ± 13 kg).
“Weight loss at nadir within the 2-year postoperative period was − 44 ± 13 kg (mean ± SD), while RWG was 9.2 ± 8.6 kg over the subsequent 3 years.”
Human trialwithin 2-year postoperative period2 years
Obesity surgery
Bariatric surgery decreases body weight in humans (severe obesity with sonographic evidence of MASLD) (TWL% 27.6 ± 7%).
“By 7 ± 1 months postoperatively, the mean weight loss was 43 ± 26 kg and TWL% was 27.6 ± 7% (p < 0.001).”
Human trialsevere obesity with sonographic evidence of MASLD7 ± 1 monthsn = 111
Scientific reports
Bariatric surgery decreases body weight in humans (30.2% vs 14.6%, p < 0.0001).
“At T3, there was greater %TWL after surgery compared with LCD (30.2% vs 14.6%; p < 0.0001).”
Human trialone year
Obesity surgery
Bariatric surgery decreases body weight in humans (body mass index ≥35 kg/m2; compared with low-calorie diet) (30% weight loss after surgery at 1 year).
“The LCD group maintained WL at T3 whereas WL was 30% after surgery.”
Human trialbody mass index ≥35 kg/m2; compared with low-calorie diet1 year
Greater Concentrations of IGF Binding Protein-2 after Bariatric Surgery Compared with Diet
Journal of the Endocrine Society
Bariatric surgery decreases body weight in humans (type 2 diabetes mellitus and hypertension) (-19.8%).
“At 90 days, weight loss in the Surgery (-19.8%) and VLCD groups (-17.4%) was significant (p < 0.0001)”
Human trialtype 2 diabetes mellitus and hypertension90 days
Journal of clinical medicine
Bariatric surgery decreases body weight in humans.
“A statistically significant decrease and large effect size was detected for anthropometric, body composition and osteoporosis parameters (p < 0.001; d > 0.8), but also in physical strength evaluated by handgrip (p < 0.001; d = 0.75) and sit-to-stand test (p = 0.011; d = 0.46).”
Human trial16 weeksn = 35
Scientific reports
Bariatric surgery decreases body weight in humans.
“SG (n = 11) and RYGB (n = 12) continued to lose weight from W11 to 1Y, whereas controls (n = 12) had regained weight.”
Human trial1 year
International journal of obesity (2005)
Bariatric surgery decreases body weight in humans (at 12 months postsurgery) (OAGB −26.7 ± 8.4%, RYGB −26.9 ± 7.3%, SG −25.1 ± 9.1%).
“At 12 months postsurgery, patients experienced significant weight loss following all procedures (OAGB −26.7 ± 8.4%, RYGB −26.9 ± 7.3%, SG −25.1 ± 9.1%, all P <.001).”
Human trialat 12 months postsurgery12 monthsn = 119
The Journal of clinical endocrinology and metabolism
Bariatric surgery decreases body weight in humans.
“OAGB, RYGB, and SG exhibited similar reductions in body weight, body fat, and lean mass (within-group comparisons, P < .001).”
Human trial12 months
The Journal of clinical endocrinology and metabolism
All 60Fewer
Mortality
downin humans12no changein humans3HR 0.25–1.14
15 studies
Mortality
downin humans12no changein humans3HR 0.25–1.14
Bariatric surgery decreases mortality in humans (40-50% reduction).
“biological age was markedly reduced in patients undergoing bariatric surgery resulting in a 40-50% reduction in expected mortality after two years, particularly in men”
Human trial2 yearsn = 505
Mortality associated biological age improves independently of weight loss after bariatric surgery
npj aging
Bariatric surgery is linked with lower mortality in patients with BMI ≥35 kg/m2 (0.46; 0.41-0.51).
“and all-cause death (0.46; 0.41-0.51).”
Humansin patients with BMI ≥35 kg/m24.7 years median follow-up
Weight-loss surgery linked to lower dementia and Parkinson's risk
International journal of obesity (2005)
Bariatric surgery is linked with lower mortality in adults with SLE (1.4% vs 4.4%, p = 0.001).
“lower CRP and ESR levels, improved eGFR, and lower mortality (1.4% vs 4.4%, p = 0.001)”
Humansin adults with SLEfive-year follow-up
Surgical endoscopy
Bariatric surgery is linked with lower mortality in humans (obese patients with hypertrophic cardiomyopathy) (1.2% vs. 2.9%; HR = 0.40; 95% CI: 0.27-0.61, p < 0.001).
“BS was associated with significantly reduced all-cause mortality (1.2% vs. 2.9%; HR = 0.40; 95% CI: 0.27-0.61, p < 0.001)”
Humansobese patients with hypertrophic cardiomyopathyup to 12 months74% females
American heart journal plus : cardiology research and practice
Bariatric surgery was not clearly linked with mortality in humans (patients operated at age over 70 years) (HR 1.14, 95% CI 0.89-1.47).
“there was no apparent benefit in patients operated at age > 70 years (HR 1.14, 95% CI 0.89-1.47)”
Humanspatients operated at age over 70 years
Mortality and Causes of Death After Metabolic Bariatric Surgery in Older Patients
Obesity surgery
Bariatric surgery is linked with lower mortality in humans (obesity) (HR 0.25, 95% CI 0.08-0.77).
“MBS was associated with a 68% reduction in all-cause mortality on univariate analysis (hazard ratio 0·32 [95% CI 0·11-0·92]; p=0·036) and a 75% reduction in all-cause mortality on multivariate analysis (0·25 [0·08-0·77]; p=0·015).”
Humansobesity
The lancet. Healthy longevity
Bariatric surgery is linked with lower mortality in humans (patients with obesity, versus usual obesity care) (HR 0.77, 95% CI 0.68-0.87).
“In total, 457 patients (22.8%) in the surgery group and 539 patients (26.4%) in the control group died (hazard ratio, 0.77; 95% confidence interval [CI], 0.68 to 0.87; P<0.001).”
Humanspatients with obesity, versus usual obesity caremedian 24 years follow-up
Life Expectancy after Bariatric Surgery in the Swedish Obese Subjects Study
The New England journal of medicine
Bariatric surgery showed no clear effect on mortality in humans (obesity; compared with incretin receptor agonists in exploratory network meta-analysis).
“All-cause mortality-representing the most direct and clinically relevant endpoint-did not differ significantly between the two strategies in the exploratory network meta-analysis.”
Reviewobesity; compared with incretin receptor agonists in exploratory network meta-analysis
European journal of preventive cardiology
Bariatric surgery showed no clear effect on mortality in humans (obesity; compared with medical treatment in network comparisons).
“Notably, all-cause mortality—representing the most direct and clinically relevant endpoint—did not differ significantly between the two strategies”
Reviewobesity; compared with medical treatment in network comparisons
ESC Congress 2026 abstract
Bariatric surgery decreases mortality in people with obesity and pre-existing cardiovascular disease (HR = 0.48, 95% CI: 0.38 to 0.61).
“Metabolic bariatric surgery was associated with a significant reduction in ACM (HR = 0.48, 95% CI: 0.38 to 0.61, p < 0.01)”
Reviewin people with obesity and pre-existing cardiovascular diseasen = 3,888
Obesity surgery
All 15Fewer
Type 2 diabetes
downin humans13−46% remission rate
13 studies
Type 2 diabetes
downin humans13−46% remission rate
Bariatric surgery is linked with lower type 2 diabetes in humans (45.8% remission rate).
“Diabetes remission rate was 45.8%.”
Humansmedian follow-up 56.2 months
Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery
Bariatric surgery decreases type 2 diabetes in humans.
“substantial improvements in type 2 diabetes, hypertension, and obstructive sleep apnea”
Review
Bariatric Surgery in the Elderly
Updates in surgery/Updates in surgery series
Bariatric surgery decreases type 2 diabetes in humans (PHTS diagnosis).
“Bariatric surgery in obese patients with PHTS diagnosis results in significant decrease in weight and complete remission of diabetes mellitus type 2.”
ReviewPHTS diagnosisfemales
Effects of Bariatric Surgery in Individuals with PTEN Hamartoma Tumor Syndrome: A Systematic Review
Obesity facts
Bariatric surgery decreases type 2 diabetes in humans (80-98% remission rates).
“Type 2 diabetes remission rates are high in both groups (80-98%).”
Review
Obesity surgery
Bariatric surgery decreases type 2 diabetes in humans.
“Significant improvements are consistently observed in weight loss, type 2 diabetes control, hypertension, and functional capacity.”
Review
Obesity surgery
Bariatric surgery decreases type 2 diabetes in patients with both type 2 diabetes mellitus and obesity.
“Bariatric surgery continues to show the most durable benefits for patients with both type 2 diabetes mellitus and obesity”
Reviewin patients with both type 2 diabetes mellitus and obesity
Treatment of Type 2 Diabetes in Patients with Obesity: A Review
Endocrinology and metabolism clinics of North America
Bariatric surgery decreases type 2 diabetes in humans (by introducing a negative energy balance).
“interventions (hypocaloric diet and/or bariatric surgery), which remove ectopic fat in the liver and pancreas by introducing a negative energy balance, can normalize insulin secretion and glucose tolerance and induce the sustained biochemical remission of type 2 diabetes”
Reviewby introducing a negative energy balance
International journal of molecular sciences
Bariatric surgery decreases type 2 diabetes in patients with obesity.
“Bariatric surgery is a powerful therapy for type 2 diabetes in patients with obesity.”
Reviewin patients with obesity
Cellular mechanism of diabetes remission by bariatric surgery
Trends in endocrinology and metabolism: TEM
Bariatric surgery decreases type 2 diabetes in humans (associated with severe obesity).
“confirming the superiority of metabolic surgery over medical treatment for the management of type 2 diabetes associated with severe obesity.”
Reviewassociated with severe obesity
Surgery for Diabetes: Clinical and Mechanistic Aspects
Canadian journal of diabetes
Bariatric surgery decreases type 2 diabetes in humans (long-term).
“These surgical procedures now emerge as the most effective therapeutic modality to induce long-term remission of type 2 diabetes.”
Reviewlong-term
Canadian journal of diabetes
All 13Fewer
Body mass index
downin humans6downin reviews1
7 studies
Body mass index
downin humans6downin reviews1
Bariatric surgery decreases body mass index in humans (from 46.7 ± 6.1 to 32.5 ± 5.1 (P < 0.0001)).
“Mean body mass index decreased from 46.7 ± 6.1 to 32.5 ± 5.1 (P < 0.0001)”
Human trialat least six monthsn = 55
Evaluation of electrocardiographic alterations before and after bariatric surgery
Global cardiology science & practice
Bariatric surgery is linked with lower body mass index in humans (compared with glp-1 receptor agonists in obese patients with hypertrophic cardiomyopathy) (-4.0 vs. -2.6 kg/m).
“BMI reduction was greater after bariatric surgery (-4.0 vs. -2.6 kg/m; P < 0.001)”
Humanscompared with glp-1 receptor agonists in obese patients with hypertrophic cardiomyopathy24 monthsn = 955
European heart journal. Quality of care & clinical outcomes
Bariatric surgery is linked with lower body mass index in adults with severe obesity and T2DM.
“Improvements in cardiometabolic parameters, including HbA1c and BMI, were also more pronounced in the surgical group.”
Humansin adults with severe obesity and T2DM12 monthsn = 190
Obesity surgery
Bariatric surgery is linked with lower body mass index in humans (obese patients with hypertrophic cardiomyopathy) (-5.0 kg/m2, p < 0.001).
“BS achieved substantial BMI reduction (-5.0 kg/m2, p < 0.001).”
Humansobese patients with hypertrophic cardiomyopathyup to 12 months74% females
American heart journal plus : cardiology research and practice
Bariatric surgery is linked with lower body mass index in humans (P < 0.001).
“The BMI decreased within 1 year and stayed constant until a slight increase at 5 years was observed.”
Humans5 yearsn = 62
Journal of computer assisted tomography
Bariatric surgery is linked with lower body mass index in humans.
“We observed a significant decrease over time in BMI, fasting glucose, HbA1c, HOMA-IR, insulin, total cholesterol, triglycerides, LDL and free fatty acids levels”
Humansover 12 monthsn = 40
Clinical epigenetics
Bariatric surgery decreases body mass index.
“the body mass index noticeably decreases”
Review
Effect of Bariatric Surgery on Metabolic Diseases and Underlying Mechanisms
Biomolecules
Body mass index
downin humans6
6 studies
Body mass index
downin humans6
Bariatric surgery decreases body mass index in humans (-11 kg/m2 (10-12.5 kg/m2)).
“A reduction of 11 kg/m2 (10-12.5 kg/m2) was observed.”
Human trial6 monthsfemalesn = 33
Cirugia y cirujanos
Bariatric surgery decreases body mass index in humans.
“A significant reduction in the BMI was observed during the postoperative evaluation (P < 0.0001).”
Human trialat least six monthsn = 55
Evaluation of electrocardiographic alterations before and after bariatric surgery
Global cardiology science & practice
Bariatric surgery is linked with lower body mass index in humans (preoperative, undergoing total knee arthroplasty) (-1.8 kg/m2).
“The BS group achieved the largest preoperative BMI reduction (–1.8 kg/m2) vs. SU (–0.7 kg/m2) and controls (+ 2.1 kg/m2).”
Humanspreoperative, undergoing total knee arthroplasty
Archives of orthopaedic and trauma surgery
Bariatric surgery is linked with lower body mass index in humans (-33 kg/m2).
“The average body mass index reduction was 33 kg/m2 (SD: 6.34).”
Humansmean 7 yearsn = 115
Cirugia y cirujanos
Bariatric surgery is linked with lower body mass index in humans (morbid obesity).
“accompanied by significant reductions in C-reactive protein (CRP), BMI and triglycerides from inclusion (p < 0.001, all).”
Humansmorbid obesity6 and 12 months80% womensn = 110
Changes in circulating sirtuin 1 after bariatric surgery
Nutrition, metabolism, and cardiovascular diseases : NMCD
Bariatric surgery decreases body mass index in humans (compared with GLP-1 RAs, at 6 months, ≤1 year and >1 year) (MD -6.77 kg/m2 at 6 months; -5.10 kg/m2 at ≤1 year; -6.61 kg/m2 at >1 year).
“BMI reduction consistently favoured BS at 6 months (MD -6.77 kg/m2; p = 0.02)”
Reviewcompared with GLP-1 RAs, at 6 months, ≤1 year and >1 year6 months to more than 1 year
Diabetes, obesity & metabolism
Body weight
downin humans4
4 studies
Body weight
downin humans4
Bariatric surgery is linked with lower body weight in humans (20.80 ± 9.71%).
“Mean %TWL was 20.80 ± 9.71% (n = 917) at 1 year”
Humans1 yearn = 917
Obesity surgery
Bariatric surgery decreases body weight in patients with obesity.
“bariatric surgery, particularly sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB), induces substantial and sustained weight loss”
Reviewin patients with obesity
Cureus
Bariatric surgery decreases body weight in humans.
“Significant improvements are consistently observed in weight loss, type 2 diabetes control, hypertension, and functional capacity.”
Review
Obesity surgery
Bariatric surgery decreases body weight in humans.
“Bariatric surgery can lead to sustained long-term weight loss (WL) and improvement in multiple obesity-related complications”
Review
Clinical medicine (London, England)
Obesity
downin humans3downin reviews1
4 studies
Obesity
downin humans3downin reviews1
Bariatric surgery decreases obesity in humans (severe or treatment-resistant obesity) (highly effective, durable outcomes).
“bariatric/metabolic surgery, such as Roux-en-Y gastric bypass and sleeve gastrectomy, offers highly effective, durable outcomes”
Reviewsevere or treatment-resistant obesity
Swiss obesity clinical practice guidance
Swiss medical weekly
Bariatric surgery decreases obesity in obesity and associated medical problems.
“Bariatric surgery, including Roux-en-Y gastric bypass and sleeve gastrectomy, is highly efficacious and a cost-effective treatment for obesity and associated medical problems.”
Reviewin obesity and associated medical problems
Biomedicines
Bariatric surgery decreases obesity in humans.
“Bariatric surgery as the so far most-effective therapeutic strategy”
Review
Pharmacology & therapeutics
Bariatric surgery decreases obesity.
“Bariatric surgery, which can be delivered in multiple forms, has been remarked as an effective treatment to decrease the prevalence of obesity and its associated comorbidities.”
Review
Effect of Bariatric Surgery on Metabolic Diseases and Underlying Mechanisms
Biomolecules
Bone mineral density
downin humans4
4 studies
Bone mineral density
downin humans4
Bariatric surgery is linked with lower bone mineral density in humans (P < 0.001).
“The BMD decreased substantially and continuously during 1-, 3-, and 5-year follow-up observations”
Humans5 yearsn = 62
Journal of computer assisted tomography
Bariatric surgery decreases bone mineral density in humans.
“Intentional weight loss through caloric restriction or bariatric surgery consistently accelerates bone turnover and reduces bone mineral density (BMD)”
Review
Beyond Weight Loss: Skeletal Considerations in Obesity Treatment
Endocrinology and metabolism (Seoul, Korea)
Bariatric surgery decreases bone mineral density in humans (obesity).
“bariatric surgery exerts multiple adverse effects on bone tissue, characterized by significantly increased bone resorption, decreased bone mineral density (BMD)”
Reviewobesitybone
Frontiers in medicine
Bariatric surgery decreases bone mineral density in humans.
“postmenopausal women demonstrating accelerated declines in bone mineral density (BMD)”
Reviewfemales
Cureus
Quality of life
upin humans4
4 studies
Quality of life
upin humans4
Bariatric surgery is linked with better quality of life in humans.
“Both SG and RYGB show favorable medium- to long-term outcomes in terms of weight loss, comorbidity resolution, and improved quality of life.”
Humansmean 7 yearsn = 115
Cirugia y cirujanos
Bariatric surgery improves quality of life in humans (severe obesity).
“alongside improvements in cardiometabolic health, quality of life, and psychosocial well-being”
Reviewsevere obesity
International journal of obesity (2005)
Bariatric surgery improves quality of life in humans.
“bariatric surgery, promoted relevant improvements in mobility, quality of life, and sexual function”
Review
Obesity beyond aesthetics: mobility, sexuality, and quality of life
Open Minds International Journal
Bariatric surgery improves quality of life in post-bariatric participants (77.7 ± 15.3 vs 58 ± 16.7).
“The QoL score was higher after surgery, ie, 77.7 ± 15.3, compared to before treatment, ie, 58 ± 16.7.”
Reviewin post-bariatric participants
Diabetes, metabolic syndrome and obesity : targets and therapy
Fat-free mass
downin humans4
4 studies
Fat-free mass
downin humans4
Bariatric surgery is linked with lower fat-free mass in humans (FFM from 61.1 ± 11.9 to 50.1 ± 7.0 kg (p < 0.001)).
“and FFM to 54.7 ± 9.5 and 50.1 ± 7.0 kg (all p < 0.001). Most FFM loss occurred within the first 6 months (mean - 6.4 kg).”
Humans12 monthsn = 179
Journal of clinical medicine
Bariatric surgery is linked with lower fat-free mass in humans (7.8% reduction at 6 months (95% CI 7.2%-8.4%); 11.7% at 24 months).
“Adjusted mean relative FFM reductions in the surgery group were 7.8% (95% CI, 7.2%-8.4%) at 6 months”
Humansrelative change at 6 months, adjusted for age, sex, race, baseline BMI, diabetes history and treatment year6 monthsn = 1,257
Body Composition Changes After Bariatric Surgery or Treatment With GLP-1 Receptor Agonists
JAMA network open
Bariatric surgery is linked with lower fat-free mass in humans.
“Fat free mass (FFM) was lower for BAR than for CON”
Humansn = 100
Journal of cachexia, sarcopenia and muscle
Bariatric surgery decreases fat-free mass in humans (-8.23 kg [95%CI -10.74; -5.73]).
“FFM loss and SMM loss were -8.23 kg [95%CI -10.74; -5.73] and -3.18 kg [95%CI -5.64; -0.71], respectively.”
Review12-month
Obesity reviews : an official journal of the International Association for the Study of Obesity
Fat mass
downin humans3−47%
3 studies
Fat mass
downin humans3−47%
Bariatric surgery decreases fat mass in humans (compared to Diet, adjusting for age and sex) (-32% (95% CI: -45%, -19%)).
“RYGB patients achieved on average lower fat mass by 32% (95% CI: -45%, -19%) than Diet and this difference remained significant after controlling for participants’ age and sex.”
Human trialcompared to Diet, adjusting for age and sex3 years (surgical groups) or 2 years (Diet group)
Endocrine
Bariatric surgery decreases fat mass in humans (46.6%).
“Roux-en-Y gastric bypass produced the greatest fat mass loss (46.6%)”
Human trial36 months
Endocrine
Bariatric surgery is linked with lower fat mass in humans (FM from 54.6 ± 10.7 to 22.0 ± 10.0 kg (p < 0.001)).
“FM decreased to 35.6 ± 11.0 and 22.0 ± 10.0 kg; and FFM to 54.7 ± 9.5 and 50.1 ± 7.0 kg (all p < 0.001).”
Humans12 monthsn = 179
Journal of clinical medicine
Bariatric surgery is linked with lower fat mass in humans (42.4% reduction at 6 months (95% CI 41.5%-43.2%); 49.7% at 24 months).
“Adjusted mean relative FM reductions in the surgery group were 42.4% (95% CI, 41.5%-43.2%) at 6 months”
Humansrelative change at 6 months, adjusted for age, sex, race, baseline BMI, diabetes history and treatment year6 monthsn = 1,257
Body Composition Changes After Bariatric Surgery or Treatment With GLP-1 Receptor Agonists
JAMA network open
Cognitive function
upin humans3
3 studies
Cognitive function
upin humans3
Bariatric surgery improves cognitive function in humans.
“Repeated measures analysis of covariance revealed improved cognitive test scores following both Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG)”
Human trial1-monthn = 111
Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery
Bariatric surgery improves cognitive function in humans.
“the surgical group performed significantly better than the control group on the forward DGS, WCST, and TMT parts A and B.”
Human trial4 monthsn = 24
Effects of bariatric surgery on cognitive function in older adults: a prospective longitudinal study
Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery
Bariatric surgery improves cognitive function in humans (severe obesity).
“Also, the patients presented a significant improvement in attention, mental flexibility, inhibitory control, and processing speed.”
Human trialsevere obesity6 monthsn = 22
Effect of bariatric surgery on neurocognitive function after 6 months of follow-up: a pilot study
Nutricion hospitalaria
Physical function
upin humans2
2 studies
Physical function
upin humans2
Bariatric surgery improves physical function in humans (at 12 months postsurgery) (6MWT: OAGB 38.0 ± 46.5%, RYGB 24.8 ± 14.6%, SG 25.0 ± 15.0%).
“The time taken to perform the STS test (OAGB −25.9 ± 29.0%, P =.021; RYGB −26.9 ± 17.8%, P <.001; SG −27.4 ± 20.6%, P <.001) and the distance covered during the 6MWT (OAGB 38.0 ± 46.5%, RYGB 24.8 ± 14.6%, SG 25.0 ± 15.0%, all P <.001) improved significantly at 12 months within all types of surgery, with no between-surgery differences in univariate or multivariate models”
Human trialat 12 months postsurgery12 monthsn = 119
The Journal of clinical endocrinology and metabolism
Bariatric surgery improves physical function in humans.
“Despite reductions in absolute handgrip strength, relative handgrip strength, STS test, and 6MWT improved postsurgery (all P < .02), with no differences by surgical procedure.”
Human trial12 months
The Journal of clinical endocrinology and metabolism
Bariatric surgery improves physical function in humans.
“gains in functional status and quality of life”
Review
Bariatric Surgery in the Elderly
Updates in surgery/Updates in surgery series
Bone mineral density
downin humans2
2 studies
Bone mineral density
downin humans2
Bariatric surgery decreases bone mineral density in humans (at 12 months postsurgery) (total hip: OAGB −9.6 ± 4.0%, RYGB −9.8 ± 3.9%, SG −6.5 ± 3.7%).
“There were significant reductions in total hip (OAGB −9.6 ± 4.0%, RYGB −9.8 ± 3.9%, SG −6.5 ± 3.7%, all P <.001), femoral neck (OAGB −7.8 ± 9.2%, P =.002, RYGB −6.7 ± 6.1%, P <.001, SG −3.3 ± 7.3%, P <.001), and lumbar spine aBMD (OAGB −4.4 ± 4.9%, P =.002, RYGB −4.5 ± 4.5%, P <.001, SG −2.0 ± 3.2%, P <.001) at 12 months after all types of surgery”
Human trialat 12 months postsurgery12 monthsn = 119
The Journal of clinical endocrinology and metabolism
Bariatric surgery decreases bone mineral density in humans.
“All surgery types were associated with reductions in aBMD at the total hip, femoral neck, and lumbar spine, which were more pronounced after OAGB and RYGB than after SG (all P < .03)”
Human trial12 months
The Journal of clinical endocrinology and metabolism
Bariatric surgery decreases bone mineral density in humans.
“Both groups had decreased bone mineral density (BMD) at all sites (lumbar spine, femoral neck, and total femur) over the 1-year follow-up (p < 0.05).”
Human trialbone1 yearfemales
Scientific reports
Telomere length
no changein humans1upin humans1
2 studies
Telomere length
no changein humans1upin humans1
Bariatric surgery showed no clear effect on telomere length in humans (morbid obesity) (p = 0.811).
“relative telomere length calculated by the 2^-ΔΔCt method did not differ significantly after surgery compared with baseline values (p = 0.811).”
Human trialmorbid obesityperipheral venous bloodone yearn = 56
Comparison of Telomere Length Differences before and after Bariatric Surgery
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
Bariatric surgery increases telomere length in humans (patients with pronounced BMI loss of >= 10 kg/m2).
“The telomere dynamics after surgery showed an increase in mean TL in both lymphocytes and granulocytes of patients with a pronounced BMI loss of ≥ 10 kg/m2.”
Human trialpatients with pronounced BMI loss of >= 10 kg/m2month 5.5 ± 3.9n = 35
Telomere length dynamics measured by flow-FISH in patients with obesity undergoing bariatric surgery
Scientific reports
All 219Fewer
What is bariatric surgery linked with?
65Studies link bariatric surgery with 65 measures, most often mortality (11 studies), cardiovascular disease (6) and bone fracture (6).
Mortality
downin humans11HR 0.48–0.76
11 studies
Mortality
downin humans11HR 0.48–0.76
Bariatric surgery is linked with a lower risk of mortality in humans (propensity-matched cohorts compared with GLP/GIP agonist treatment) (RR 0.561 (95% CI 0.524–0.600)).
“Bariatric surgery was associated with significantly lower risk of mortality (RR 0.561, 95% CI: 0.524–0.600, p < 0.001)”
Humanspropensity-matched cohorts compared with GLP/GIP agonist treatment90 to 1,095 days post-index
AHA Scientific Sessions 2025 abstract
Bariatric surgery is linked with a lower risk of mortality in humans (patients with CKD and severe obesity) (HR 0.48 (95% c.i. 0.34 to 0.67)).
“MBS was associated with 52% lower hazards of mortality (HR 0.48 (95% c.i. 0.34 to 0.67))”
Humanspatients with CKD and severe obesitymedian of 7.7 yearsn = 1,538
The British journal of surgery
Bariatric surgery is linked with a lower risk of mortality in humans (severe obesity) (HR 0.76, 95% CI 0.64,0.91).
“with a decreased risk of mortality (HR 0.76, 95% CI 0.64,0.91)”
Humanssevere obesity
PloS one
Bariatric surgery is linked with a lower risk of mortality in humans (Medicare beneficiaries with heart failure and class II obesity, propensity-matched) (HR 0.55 [95% CI 0.49-0.63]).
“bariatric surgery was associated with lower risk of all-cause mortality (HR, 0.55 [95% CI, 0.49-0.63]; P<0.001)”
HumansMedicare beneficiaries with heart failure and class II obesity, propensity-matchedmedian follow-up 4.7 yearsn = 2,594
Circulation. Heart failure
Bariatric surgery is associated with mortality in humans (obese patients).
“BS was associated with a reduction in mortality”
Humansobese patients
Bariatric Surgery Should Be Proposed in Certain Septuagenarian Patients with Obesity
Obesity surgery
Bariatric surgery is linked with a lower risk of mortality in humans (versus matched medically managed elderly patients with obesity).
“There was a statistically significant decrease in the risk of death in ElderSurg (hazard ratio .584, 95% confidence interval .362-.941) compared with ElderNonSurg.”
Humansversus matched medically managed elderly patients with obesitymedian follow-up 56.2 monthsn = 337
Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery
Bariatric surgery is associated with mortality in humans (obesity; compared with control) (HR 0.57, 95% CI 0.51–0.65).
“Compared with control, bariatric surgery was associated with a significant reduction in all evaluated outcomes, including all-cause mortality (HR:0.57, 95%CI:0.51–0.65)”
Reviewobesity; compared with control
European journal of preventive cardiology
Bariatric surgery is associated with mortality in humans (obesity; compared with control) (HR 0.56, 95% CI 0.49–0.64).
“Compared with control, bariatric surgery significantly reduced all evaluated outcomes, including all-cause mortality (HR: 0.56, 95%CI: 0.49–0.64)”
Reviewobesity; compared with control
ESC Congress 2026 abstract
Bariatric surgery lowers the risk of mortality in humans (compared with conservative treatment in patients with obesity).
“bariatric surgery is associated with lower rates of major adverse cardiovascular events (MACEs), coronary artery disease (CAD), heart failure, myocardial infarction (MI), stroke, and all-cause mortality”
Reviewcompared with conservative treatment in patients with obesity
Cureus
Bariatric surgery is associated with mortality in humans (compared with non-surgical care).
“associated with durable weight loss and lower observed rates of MACE, heart failure and all-cause mortality compared with non-surgical care”
Reviewcompared with non-surgical care
Heart (British Cardiac Society)
All 11Fewer
Cardiovascular disease
downin humans6HR 0.55
6 studies
Cardiovascular disease
downin humans6HR 0.55
Bariatric surgery is linked with a lower risk of cardiovascular disease in patients with BMI ≥35 kg/m2 (0.53; 0.51-0.56).
“Similar associations were observed for CVD (0.53; 0.51-0.56);”
Humansin patients with BMI ≥35 kg/m24.7 years median follow-up
Weight-loss surgery linked to lower dementia and Parkinson's risk
International journal of obesity (2005)
Bariatric surgery is linked with a lower risk of cardiovascular disease in patients with diabetes.
“This new analysis finds a reduction in risk of CVD in patients with diabetes, consistent with preexisting evidence.”
Humansin patients with diabetes
Epidemiology (Cambridge, Mass.)
Bariatric surgery lowers the risk of cardiovascular disease in humans (compared with conservative treatment in patients with obesity).
“bariatric surgery is associated with lower rates of major adverse cardiovascular events (MACEs), coronary artery disease (CAD), heart failure, myocardial infarction (MI), stroke”
Reviewcompared with conservative treatment in patients with obesity
Cureus
Bariatric surgery lowers the risk of cardiovascular disease in people with obesity and pre-existing cardiovascular disease (HR = 0.55, 95% CI: 0.45 to 0.67).
“Metabolic bariatric surgery was associated with a significant reduction in ACM (HR = 0.48, 95% CI: 0.38 to 0.61, p < 0.01) and MACE (HR = 0.55, 95% CI: 0.45 to 0.67, p < 0.01).”
Reviewin people with obesity and pre-existing cardiovascular diseasen = 3,888
Obesity surgery
Bariatric surgery lowers the risk of cardiovascular disease in type 2 diabetes.
“Bariatric surgery achieves even greater improvements in cardiovascular disease outcomes than treatments with these newer pharmacological agents.”
Reviewin type 2 diabetes
International journal of molecular sciences
Bariatric surgery lowers the risk of cardiovascular disease in patients with obesity (RR = 0.63; 95% CI: 0.49-0.81).
“MBS was associated with a significantly lower prevalence of CVD (RR = 0.63; 95% CI: 0.49-0.81; I2 = 87.7%)”
Reviewin patients with obesity
Obesity surgery
Bone fracture
upin humans6
6 studies
Bone fracture
upin humans6
Bariatric surgery is linked with a higher risk of bone fracture in humans (compared to medical weight management controls) (crude odds ratio of 2.71 (95% CI 1.69-4.36)).
“The fracture rate was higher in the surgical group as compared to the controls (9.4% vs 3.5%) with a crude odds ratio of 2.71 (95% CI 1.69-4.36).”
Humanscompared to medical weight management controls8.6 years
Increased Fracture Risk After Bariatric Surgery: a Case-Controlled Study with a Long-Term Follow-Up
Obesity surgery
Bariatric surgery raises the risk of bone fracture in humans (obesity).
“significantly increased bone resorption, decreased bone mineral density (BMD), and a consequent elevation in fracture risk.”
Reviewobesitybone
Frontiers in medicine
Bariatric surgery raises the risk of bone fracture in humans (especially malabsorptive procedures).
“increased risk of fracture after MBS, especially malabsorptive procedures”
Reviewespecially malabsorptive procedures
Effects of weight-loss interventions on bone health in people living with obesity
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Bariatric surgery raises the risk of bone fracture in humans (especially malabsorptive procedures).
“associated with an increased risk of fracture after bariatric surgery especially malabsorptive procedures”
Reviewespecially malabsorptive procedures
Calcified tissue international
Bariatric surgery raises the risk of bone fracture in humans.
“There is an increased risk of fracture after bariatric surgery.”
Review
Joint bone spine
Bariatric surgery raises the risk of bone fracture in humans (21-44%).
“Based on observational studies, bariatric surgery is associated with a 21-44% higher risk of all fractures.”
Review
Bone
Endometrial cancer
downin humans4
4 studies
Endometrial cancer
downin humans4
Bariatric surgery is associated with endometrial cancer in humans (Individuals with obesity; compared with no surgery) (aIRR 0.51, 95% CI 0.45–0.59).
“endometrial cancer (aIRR, 0.51; 95% CI, 0.45-0.59)”
HumansIndividuals with obesity; compared with no surgery
Weight-loss surgery linked to lower obesity-related cancer risk
JAMA surgery
Bariatric surgery lowers the risk of endometrial cancer in humans (durable metabolic correction).
“Bariatric surgery offers the strongest human evidence supporting the principle that durable metabolic correction can substantially reduce EC incidence.”
Reviewdurable metabolic correction
Biomedicines
Bariatric surgery lowers the risk of endometrial cancer in patients with obesity/endometrial cancer.
“weight-loss surgery has been proven to reduce the incidence and mortality of endometrial cancer”
Reviewin patients with obesity/endometrial cancer
The role and effects of metabolic and bariatric surgery on endometrial cancer care
Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery
Bariatric surgery lowers the risk of endometrial cancer in humans.
“Bariatric surgery is the gold standard for successful weight loss and highlights how reversing of the systemic effects of obesity can reduce EC risk.”
Review
Biochimica et biophysica acta. Reviews on cancer
Cancer
downin humans4
4 studies
Cancer
downin humans4
Bariatric surgery is linked with a lower risk of cancer in humans (obesity-associated cancers in patients with BMI ≥35 kg/m2) (0.66; 0.60-0.72).
“obesity-associated cancers (0.66; 0.60-0.72)”
Humansobesity-associated cancers in patients with BMI ≥35 kg/m24.7 years median follow-up
Weight-loss surgery linked to lower dementia and Parkinson's risk
International journal of obesity (2005)
Bariatric surgery lowers the risk of cancer in humans (individuals with severe obesity).
“associated with a reduction in overall cancer risk and cancer-related mortality, particularly for malignancies strongly linked to obesity”
Reviewindividuals with severe obesity
Nutrients
Bariatric surgery lowers the risk of cancer in individuals with obesity.
“Metabolic and bariatric surgery (MBS) leads to greater maximum and sustained weight loss than nonsurgical dietary strategies and demonstrates the most convincing evidence that weight loss lowers cancer risk.”
Reviewin individuals with obesity
Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery
Bariatric surgery lowers the risk of cancer in humans (severe obesity).
“Decreases in cancer, diabetes, and cardiovascular-related mortality are major contributors to this overall effect on life expectancy after bariatric surgery”
Reviewsevere obesity
Resolution of Comorbidities and Impact on Longevity Following Bariatric and Metabolic Surgery
The Surgical clinics of North America
Type 2 diabetes
downin humans4−79% to −53% remission
4 studies
Type 2 diabetes
downin humans4−79% to −53% remission
Bariatric surgery lowers the risk of type 2 diabetes in humans (severe sarcopenic obesity) (75% remission).
“Remission rates for comorbidities were substantial among all groups, but more marked among patients within group 1 (type 2 diabetes mellitus 75%”
Human trialsevere sarcopenic obesity1 yearfemales
Obesity surgery
Bariatric surgery is linked with a lower risk of type 2 diabetes in humans (vs non-surgery) (2.6% vs 9.2%, p=0.02).
“Incident T2D was lower (2.6% [0.5-7.4] vs 9.2% [6.7-12.2], p=0.02)”
Humansvs non-surgery6.1 years
Six-year Follow-Up of Nonpharmacological and Nonsurgical Obesity Treatments
Diabetes, metabolic syndrome and obesity : targets and therapy
Bariatric surgery is linked with a lower risk of type 2 diabetes in humans (severe obesity) (79.1% remission).
“Remission occurred in 79.1% of individuals with T2DM, 36.0% with HT, 33.9% with DLP, and 79.6% with MetS.”
Humanssevere obesity1-5 yearsn = 581
Journal of clinical medicine
Bariatric surgery is linked with a lower risk of type 2 diabetes in humans after primary laparoscopic bariatric surgery (52.8% remission).
“Older patients had a higher prevalence of type 2 diabetes and hypertension, with remission rates of 52.8% and 40.5%, respectively”
Humansafter primary laparoscopic bariatric surgery10 yearsn = 46
Metabolic Bariatric Surgery in Older Patients: Is It Worth It? BARI-10-POL Study
Obesity surgery
Heart failure
downin humans4HR 0.76
4 studies
Heart failure
downin humans4HR 0.76
Bariatric surgery is linked with a lower risk of heart failure in humans (obese patients with hypertrophic cardiomyopathy) (8.6% vs. 10.7%; HR = 0.76; 95% CI: 0.63-0.90, p < 0.002).
“acute heart failure hospitalization (8.6% vs. 10.7%; HR = 0.76; 95% CI: 0.63-0.90, p < 0.002)”
Humansobese patients with hypertrophic cardiomyopathyup to 12 months74% females
American heart journal plus : cardiology research and practice
Bariatric surgery is linked with a lower risk of heart failure in adult heart transplant recipients with BMI >= 35 kg/m2 (13 vs. 24, OR 0.12, p = 0.003).
“Heart failure rates were significantly lower in HTR/BS cohort at 1 and 3 years, but not at 5 years (13 vs. 24, OR 0.12, p = 0.003”
Humansin adult heart transplant recipients with BMI >= 35 kg/m21 year
The Weight of a New Heart: Bariatric Surgery after Heart Transplantation and its Clinical Impact
Obesity surgery
Bariatric surgery is linked with a lower risk of heart failure in humans (propensity-matched cohorts compared with GLP/GIP agonist treatment) (RR 0.578 (95% CI 0.531–0.630)).
“HF (RR 0.578, 95% CI: 0.531–0.630, p < 0.001)”
Humanspropensity-matched cohorts compared with GLP/GIP agonist treatment90 to 1,095 days post-index
AHA Scientific Sessions 2025 abstract
Bariatric surgery lowers the risk of heart failure in patients with obesity (RR = 0.50; 95% CI: 0.37-0.66).
“and HF (RR = 0.50; 95% CI: 0.37-0.66; I2 = 70.2%) compared to GLP-1RAs.”
Reviewin patients with obesity
Obesity surgery
Dementia
downin humans2upin humans1HR 1.33
3 studies
Dementia
downin humans2upin humans1HR 1.33
Bariatric surgery is linked with a lower risk of dementia in patients with BMI ≥35 kg/m2 (hazard ratio 0.48, 95% CI: 0.39-0.58).
“individuals who underwent BS had significantly reduced incidence rates of dementia (hazard ratio 0.48, 95% CI: 0.39-0.58)”
Humansin patients with BMI ≥35 kg/m24.7 years median follow-up
Weight-loss surgery linked to lower dementia and Parkinson's risk
International journal of obesity (2005)
Bariatric surgery is linked with a lower risk of dementia in patients with obesity and T2D (SHR 0.60, 95% CI 0.47-0.76).
“MBS was associated with a reduced risk of dementia (15-year cumulative incidence 1.8% vs. 2.7%, subdistribution hazard ratio [SHR] 0.60, 95% CI 0.47-0.76).”
Humansin patients with obesity and T2D9 years
Weight-loss surgery linked to lower dementia risk
Alzheimer's & dementia : the journal of the Alzheimer's Association
Bariatric surgery is associated with dementia in humans (Compared with matched non-surgical subjects; adjusted for covariates) (HR 1.33; dementia incidence 1.4% versus 0.5%; p = 0.02).
“the surgery group had a higher risk for dementia incidence than the matched non-surgery subjects (HR = 1.33, p = 0.02).”
HumansCompared with matched non-surgical subjects; adjusted for covariatesMean follow-up of 10.5 years78% femalesn = 51,078
Development of dementia in patients who underwent bariatric surgery
Surgical endoscopy
Atrial fibrillation
downin humans3RR 0.31–0.892
3 studies
Atrial fibrillation
downin humans3RR 0.31–0.892
Bariatric surgery is linked with a lower risk of atrial fibrillation in humans (propensity-matched cohorts compared with GLP/GIP agonist treatment) (RR 0.892 (95% CI 0.828–0.960)).
“Afib (RR 0.892, 95% CI: 0.828–0.960, p = 0.002)”
Humanspropensity-matched cohorts compared with GLP/GIP agonist treatment90 to 1,095 days post-index
AHA Scientific Sessions 2025 abstract
Bariatric surgery is linked with a lower risk of atrial fibrillation in humans (Medicare beneficiaries with heart failure and class II obesity, propensity-matched) (HR 0.78 [95% CI 0.65-0.93]).
“lower atrial fibrillation risk (HR, 0.78 [95% CI, 0.65-0.93]; P=0.006)”
HumansMedicare beneficiaries with heart failure and class II obesity, propensity-matchedmedian follow-up 4.7 yearsn = 2,594
Circulation. Heart failure
Bariatric surgery lowers the risk of atrial fibrillation in humans (post-ablation) (RR = 0.31 [0.13 to 0.75]).
“Bariatric surgery was associated with reduced risk of AF recurrence (RR = 0.31 [0.13 to 0.75])”
Reviewpost-ablation
Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing
Sarcopenia
upin humans3
3 studies
Sarcopenia
upin humans3
Bariatric surgery is linked with a higher risk of sarcopenia in humans (10 years post-surgery patients compared to 5 years).
“while the last had enhanced sarcopenia”
Humans10 years post-surgery patients compared to 5 years10 yearsn = 14
Metabolic Bariatric Surgery Effects on Skeletal Muscles and Adipose Tissues
ADA Scientific Sessions 2025 abstract
Bariatric surgery raises the risk of sarcopenia in humans.
“This narrative review synthesizes contemporary evidence on late complications across procedures, including nutritional and mineral deficiencies, sarcopenia, bone health disorders, dumping syndrome, nephrolithiasis, and mental health outcomes”
Review
A Contemporary Perspective on Long-Term Complications of Bariatric Surgery
Obesity surgery
Bariatric surgery raises the risk of sarcopenia in humans.
“However, it is not risk-free, especially in a vulnerable population, predisposing to falls, fractures and sarcopenia.”
Review
Sheer drop ahead: reviewing sarcopenia outcomes in elderly patients undergoing bariatric surgery
Reviews in endocrine & metabolic disorders
Obstructive sleep apnea
downin humans1
1 study
Obstructive sleep apnea
downin humans1
Bariatric surgery lowers the risk of obstructive sleep apnea in participants with baseline OSA (-32.1 percentage points, 95% CI -36.9 to -27.2, p < 0.001).
“bariatric surgery was associated with a 32.1 percentage points lower prevalence of OSA in participants with baseline OSA (95% CI: -36.9 to -27.2; p < 0.001) compared to usual care”
Human trialin participants with baseline OSA20 years
Obesity (Silver Spring, Md.)
Circulating proteome
mixedin humans1
1 study
Circulating proteome
mixedin humans1
Bariatric surgery is associated with circulating proteome in humans (23 proteins).
“Twenty-three proteins were altered in a consistent direction after both bariatric surgery and caloric restriction”
Human trial
Scientific reports
All 65Fewer
Funding
26 grants since 2016National Institute of Diabetes and Digestive and Kidney Diseases$9.2MNational Heart, Lung, and Blood Institute$4.5MNational Institute for Health Research£2.6M
National Institute of Diabetes and Digestive and Kidney DiseasesSeattle Inst for Biomedical/clinical Res$272K2026–2030
National Institute of Diabetes and Digestive and Kidney DiseasesKaiser Foundation Research Institute$650K2024–2028
National Institute of Diabetes and Digestive and Kidney DiseasesHartford Hospital$573K2024–2028
National Institute of Diabetes and Digestive and Kidney DiseasesIntailor Bariatrics$325K2025–2026
National Institute on AgingUniversity of Wisconsin-madison$311K2025–2027
São Paulo Research FoundationFundação Faculdade de Medicina2025–2028
Changes in CSF Biomarkers after Bariatric Surgery
National Institute of Diabetes and Digestive and Kidney DiseasesColumbia University Health Sciences$466K2020–2026
American Heart AssociationUniversity of Southern California$33.7K2024
Role of Meal Timing in Efficacy of Bariatric Surgery in Obese Individuals
National Heart, Lung, and Blood InstituteBrigham and Women's Hospital$635K2017–2025
The role of GLP-1 in cardiac recovery after bariatric surgery in obesity-induced heart failure
National Heart, Lung, and Blood InstituteMedical College of Wisconsin$151K2019–2022
How this record changed
Summary rewritten as its findings changed.
As it read before
Human cohorts link bariatric surgery with lower mortality in people with obesity, a pattern reported by independent labs; other reports show no clear mortality or cardiovascular association. Human trials report improved physical function but decreased hip bone density and lean mass. Some papers declare ties to Novo Nordisk and AstraZeneca.
Summary rewritten as its findings changed.
As it read before
Independent human studies associate bariatric surgery with lower mortality in obesity; cohorts also report lower cardiovascular risk, although other studies report no change in either outcome. Telomeres lengthen across independent labs but remain unchanged in other studies; human trials report improved physical function alongside reduced bone density and lean mass. Some papers declare company ties.
Summary rewritten as its findings changed.
As it read before
Bariatric surgery is associated with lower mortality and dementia risk in human studies of people with obesity. Independent labs report telomere lengthening, but other studies report no telomere or epigenetic-age change; long-term follow-up also reports increased fracture risk. Some papers declare ties to Amgen, Abbott, AstraZeneca, and other companies.
Summary rewritten as its findings changed.
As it read before
A human study reports lower liver stiffness and controlled attenuation parameter after bariatric surgery in obesity with MASLD; another reports reduced AI-ECG age gap after the first postoperative year. Reviews describe weight loss and lower cardiovascular risks in obesity.
Summary written from the findings.